Real-World Outcomes of Peri-Operative Chemotherapy With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel in Upper Gastrointestinal Cancers: An Audit of Patients Diagnosed Between 2017 and 2020 at the Christie Hospital.

Sabry M, Mahmoud Y, Hatahet Y, Patel R, Ibrahim N

Open source

DOI
10.7759/cureus.97905
Published
2025 Nov
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.97905,
  title = {Real-World Outcomes of Peri-Operative Chemotherapy With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel in Upper Gastrointestinal Cancers: An Audit of Patients Diagnosed Between 2017 and 2020 at the Christie Hospital.},
  author = {Sabry M and Mahmoud Y and Hatahet Y and Patel R and Ibrahim N},
  year = {2025},
  journal = {Cureus},
  doi = {10.7759/cureus.97905},
  url = {https://doi.org/10.7759/cureus.97905}
}

RIS

TY  - JOUR
TI  - Real-World Outcomes of Peri-Operative Chemotherapy With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel in Upper Gastrointestinal Cancers: An Audit of Patients Diagnosed Between 2017 and 2020 at the Christie Hospital.
AU  - Sabry M
AU  - Mahmoud Y
AU  - Hatahet Y
AU  - Patel R
AU  - Ibrahim N
PY  - 2025
JO  - Cureus
DO  - 10.7759/cureus.97905
UR  - https://doi.org/10.7759/cureus.97905
ER  - 

APA

M, S., Y, M., Y, H., R, P., & N, I. (2025). Real-World Outcomes of Peri-Operative Chemotherapy With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel in Upper Gastrointestinal Cancers: An Audit of Patients Diagnosed Between 2017 and 2020 at the Christie Hospital.. Cureus. https://doi.org/10.7759/cureus.97905

Source records